By Joe Hoppe
Indivior said it has extended its relationship agreement with shareholder Scopia Capital Management, extending the board tenure of director Jerome Lande, who is Scopia’s representative, until the end of 2024.
The U.K.-listed pharmaceutical company said Friday that Scopia, which holds a 7.0% stake, is a valued longstanding shareholder,…
